Diagnosis and treatment of perianal fistulas in Crohn disease

Annals of Internal Medicine

Volumn 135, Issue 10, 2001, Pages 906-918

  Schwartz, D A ^a   Pemberton, J H ^a   Sandborn, W J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CYCLOSPORIN; INFLIXIMAB; MERCAPTOPURINE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ALGORITHM; ANTIBIOTIC THERAPY; ANUS FISTULA; CROHN DISEASE; DISEASE CLASSIFICATION; DRUG EFFICACY; FISTULOTOMY; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; TREATMENT PLANNING;

EID: 0035923424     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-135-10-200111200-00011     Document Type: Review

References (123)

1. National Cooperative Crohn's Disease Study: Extraintestinal manifestations and perianal complications
2. Clinical patterns in Crohn's disease: A statistical study of 615 cases
3. Anal complications in Crohn's disease
4. Natural history of perianal Crohn's disease. Ten year follow-up: A plea for conservatism
5. Crohn's disease of the colon. I. Fistula in Crohn's disease of the colon, classification presenting features and management in 63 patients
6. Management of perianal Crohn's disease
7. Perianal fistulas in patients with Crohn's disease
8. Perianal complications in Crohn's disease
9. Perianal lesions in Crohn's disease
10. Anal fistulas in Crohn's disease
11. Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease
12. The natural history of fistulizing Crohn's disease
13. Symposium. Crohn's disease: Anal lesions
14. The pathogenesis and treatment of fistula-in-ano
15. Surgical pathology and management of anorectal Crohn's disease
16. Clinical classification of perianal Crohn's disease
17. Fistulo-in-ano
18. A classification of fistula-in-ano
19. Health status in inflammatory bowel disease. Biological and behavioral considerations
20. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study
21. Infliximab for the treatment of fistulas in patients with Crohn's disease
22. Usual therapy improves perianal Crohn's disease as measured by a new disease activity index
23. Outcome after surgery for perianal fistula: Predictive value of MR imaging
24. Internal fistulas in Crohn's disease
25. The dilemma of Crohn's disease: Ileosigmoidal ileosigmoidal fistula complicating Crohn's disease
26. Fistulography for fistula-in-ano. Is it useful?
27. Radiologic diagnosis of anal fistulae with radio-opaque markers
28. The role of fistulography in fistula-in-ano. Report of five cases
29. Endoscopic ultrasonography versus computed tomography in the differential diagnosis of perianorectal complications in Crohn's disease
30. Value of transrectal ultrasonography in Crohn's disease
31. CT evaluation of Crohn's disease: Effect on patient management
32. Computed tomography in Crohn's disease
33. Crohn disease: Perirectal and perianal findings at CT
34. Computed tomography in the evaluation of Crohn disease
35. Computed tomography evaluation of local and extraintestinal complications of Crohn's disease
36. Pelvic and perineal complications of Crohn's disease: Assessment using magnetic resonance imaging
37. Magnetic resonance imaging in perianal Crohn's disease
38. Diagnosis of fistulae and sinus tracts in patients with Crohn disease: Value of MR imaging
39. Endosonography of peri-anal and peri-colorectal fistula and/or abscess in Crohn's disease
40. Endosonography (transrectal and transvaginal) in the assessment of perianorectal fistulas and abscesses: Experience with 127 cases
41. Prospective comparison of endosonography, magnetic resonance imaging and surgical findings in anorectal fistula and abscess complicating Crohn's disease
42. Metronidazole for Crohn's disease
43. Healing of perineal Crohn's disease with metronidazole
44. Treatment of Crohn's disease with metronidazole
45. Metronidazole therapy for Crohn's disease and associated fistulae
46. Metronidazole in the treatment of Crohn disease. Results of a controlled randomized prospective study
47. Metronidazole therapy for perineal Crohn's disease: A follow-up study
48. Is there a role for antibiotics as primary therapy in Crohn's ileitis?
49. Long-term outcome of ciprofloxacin treatment in severe perianal or fistulous Crohn's disease
50. Treatment of Crohn's disease with azathioprine: A controlled evaluation
51. A controlled trial of azathioprine in Crohn's disease
52. Controlled trial of azathioprine in Crohn's disease
53. Controlled trial of azathioprine in Crohn's disease
54. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis
55. 6-Mercaptopurine in the management of inflammatory bowel disease: Short- and long-term toxicity
56. Antitumor necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results, and safety
57. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease
58. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation
59. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease
60. Infliximab and Crohn's disease
61. A randomized controlled trial of CDP571, A humanized antibody to TNF alpha, in moderately to severely active Crohn's disease
62. Review article: Safety of infliximab in clinical trials
63. Effects of cyclosporin A on active Crohn's disease
64. Cyclosporine therapy in inflammatory bowel disease: Open-label experience
65. Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A
66. Efficacy of cyclosporine in treatment of fistula of Crohn's disease
67. Long-term 6-mercaptopurine treatment in adolescents with Crohn's disease
68. Continuous infusion cyclosporine ineffective for severe acute Crohn's disease ... but for how long?
69. Cyclosporine A induces remission in fistulous Crohn's disease but relapse occurs upon cessation of treatment
70. Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease
71. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine
72. Cyclosporine therapy in inflammatory bowel disease: Short-term and long-term results
73. Cyclosporine therapy for inflammatory bowel disease: Definitive answers and remaining questions
74. A critical review of cyclosporine therapy in inflammatory bowel disease
75. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae
76. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease
77. Steroid-unresponsive acute attacks of inflammatory bowel disease: Immunomodulation by tacrolimus (FK506)
78. Use of elemental diet during the adaptive stage of shott gut syndrome
79. Levamisole in the treatment of Crohn's disease
80. Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease
81. Elemental diet therapy in the management of complicated Crohn's disease
82. Ten years' experience with an elemental diet in the management of Crohn's disease
83. Comparison of total parenteral nutrition and elemental diet in induction of remission of Crohn's disease. Long-term maintenance of remission by personalized food exclusion diets
84. Efficacy of nutritional therapy for active Crohn's disease
85. Parenteral nutrition in Crohn's disease
86. Total parenteral nutrition as primary therapy for inflammatory disease of the bowel
87. Controlled trial of bowel rest and nutritional support in the management of Crohn's disease
88. Elemental diets in the management of Crohn's perianal fistulae
89. Initial experience with mycophenolate mofetil in the treatment of severe inflammatory bowel disease
90. Mycophenolate mofetil in patients with Crohn's disease
91. The place of methotrexate in the treatment of refractory Crohn's disease
92. An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease
93. Thalidomide therapy for patients with refractory Crohn's disease: An open-label trial
94. Treatment of fistulas with granulocyte colonystimulating factor in a patient with Crohn's disease
95. Healing of severe perineal and cutaneous Crohn's disease with hyperbaric oxygen
96. Hyperbaric oxygen and perineal Crohn's disease: A follow-up
97. Closure of refractory perineal Crohn's lesion. Integration of hyperbaric oxygen into case management
98. Hyperbaric oxygen for perianal Crohn's disease
99. Hyperbaric oxygenation in severe perineal Crohn's disease
100. Perianal abscess in Crohn's disease
101. Anorectal Crohn's disease: Definitive surgery for fistulas and recurrent abscesses
102. Surgical treatment of anorectal fistula in patients with Crohn's disease
103. Techniques and results in the management of anal and perianal Crohn's disease
104. Experience with perirectal fistulas in patients with Crohn's disease
105. Fistula-in-ano in Crohn's disease. Results of aggressive surgical treatment
106. Twenty-year review of the surgical management of perianal Crohn's disease
107. Anovaginal and rectovaginal fistulas in Crohn's disease
108. Anal fistulas in Crohn's disease: Incidence and outcome of surgical treatment
109. Seton management of complex anorectal fistulas in patients with Crohn's disease
110. Seton treatment for perianal Crohn's fistulas
111. Evaluation of surgery for perianal Crohn's fistulas
112. Surgery for Crohn's anal fistulas
113. Seton treatment of high anal fistulae
114. Clinical course after transanal advancement flap repair of perianal fistula in patients with Crohn's disease
115. Endorectal advancement flap in perianal Crohn's disease
116. The effect of split ileostomy on perianal Crohn's disease
117. Loop ileostomy in the management of Crohn's colitis in the debilitated patient
118. Anorectal Crohn's disease. A long-term perspective
119. Carcinoma arising in anorectal fistulas of Crohn's disease
120. The relationship between fistulas in Crohn's disease and associated carcinoma. Report of four cases and review of the literature
121. Adenocarcinoma in perineal fistulas of Crohn's disease
122. Primary adenocarcinoma in an enterocutaneous fistula associated with Crohn's disease